
TikTok files legal challenge of federal government's shutdown orderShares of chipmaker Advanced Micro Devices ( AMD -5.57% ) fell 5.4% in Monday trading, as of 2 p.m. ET. The semiconductor stock fell today on the heels of an analyst downgrade from a Wall Street sell-side analyst, capping off a difficult few trading days for the artificial intelligence (AI) hopeful. Bank of America downgrades Today, Bank of America analyst Vivek Arya downgraded AMD to neutral from buy, while lowering his price target from $180 to $155. The timing of today's downgrade was also noteworthy. On Friday, AMD's stock also declined following a statement from an Amazon executive that Amazon Web Services (AWS), the largest cloud platform on the planet, was "not yet seeing" demand for AMD's MI300 roster of AI GPUs. AMD had hoped to make inroads in the exploding AI market, but at least this quote suggests the major clouds are either buying leader Nvidia 's most advanced chips or merely making their own in-house designed training chips at lower cost. Just last week, Amazon said its Trainium2 chips were available, and that it was building a "supercluster" with said Trainium chips for outside customers and AI start-up Anthropic, in which Amazon has invested. Apparently, BofA sees the rise of cheaper internally made chips from all cloud providers, as well as Nvidia's upcoming Blackwell chip, as crowding out the opportunity for AMD in AI. Additionally, Arya noted some have projected soft PC demand in the first half of 2025, which could further weigh on AMD results. AMD could be vulnerable AMD has been a stock market darling for a number of years, but that has pushed its valuation up to 122 times earnings and nearly 30 times next year's projections . With expectations so high, it's perhaps not surprising to see the stock react this harshly on today's downgrade.Pulmonx director French sells $132,600 in stock
Jimmy Carter, who built a humanitarian legacy after presidency marked by crises, dies at 100
Empowering confidence in digital payments: Mastercard's commitment to cybersecurity in T&T
A petition calling for the “immediate suspension” of mRNA Covid vaccines has attracted a number of high-profile backers — including the man picked by US President-elect Donald Trump to lead the country’s main public health research agency. The Hope Accord, an online petition launched earlier this year, states that a “growing body of evidence suggests the widespread rollout of the novel Covid-19 mRNA vaccine products is contributing to an alarming rise in disability and excess deaths”. Such claims have repeatedly been rejected by public health authorities and leading medical experts. “This new technology was granted emergency use authorisation to address a situation that no longer exists,” the petition states. “Going forward, the burden of proof falls on those still advocating for these products to compellingly demonstrate that they aren’t resulting in net harm. Until such evidence is presented, regulators should suspend their use as a matter of standard medical precaution.” The petition was co-created by Dr Joseph Fraiman, a Louisiana-based ER physician and medical researcher. Dr Fraiman was the lead author of a study last year that reanalysed Pfizer and Moderna’s original randomised trials, concluding that the rate of serious harm from the vaccines was one in 800, far higher than previously suggested. Dr Jay Bhattacharya, a vocal critic of Covid lockdowns who has been picked by Mr Trump to run the National Institutes of Health (NIH), called Dr Fraiman’s study “probably the most important paper during the pandemic” about Covid vaccines. Stanford University infectious diseases specialist Dr Jay Bhattacharya. Picture: Supplied “It was a very rigorous paper and I think [it] had probably the biggest impact in my thinking about the safety of vaccines,” Dr Bhattacharya said in a July interview with Dr Fraiman for his podcast, The Illusion of Consensus . Writing on X at the time, Dr Bhattacharya said the debate had convinced him to sign the petition calling for the vaccines’ regulatory authorisation to be pulled. “I hesitated to sign because I was concerned that some patient groups may still benefit from it,” he said. “Joe, very reasonably, asked me how we could know who falls into those categories. The answer, of course, would come from randomised clinical trial evidence with solid clinical endpoints like prevention of long Covid, hospitalisation or death. “By the end of the debate, Joe had convinced me that not pulling the authorisation makes it more likely that we will never get good clinical trial evidence testing to check whether such groups still exist in a setting of widespread recovered immunity.” New on my Illusion of Consensus podcast, I debate with @JosephFraiman on his HOPE Accord, a public petition to restore ethics to public health and to pull regulatory authorization for the marketing of the covid mRNA vaccine. I hesitated to sign because I was concerned that some⦠— Jay Bhattacharya (@DrJBhattacharya) July 11, 2024 Dr Bhattacharya’s public support for the petition is noteworthy as he could soon be in charge of the NIH’s $US47 billion ($74 billion) annual budget, which funds research into vaccines, cancer and other diseases. His nomination would need to be approved by the Senate. The Hope Accord petition also calls for a “comprehensive re-evaluation” of the safety and efficacy of all Covid vaccines, including a “full exploration of mechanisms of harm to provide insight into their impact on the human body, both short and long term”. “Effectiveness must be reassessed through a comprehensive review of actual clinical impact on illness and mortality, as opposed to synthetic results based on modelled assumptions,” it states. A vaccination centre at University College London Hospital. Picture: Tolga Akmen/AFP ‘Conspiracy theories’ British cardiologist Aseem Malhotra, who co-created the petition, published an open letter on Tuesday in response to a long-running disciplinary probe by the UK’s General Medical Council (GMC) over complaints he was spreading “Covid vaccine misinformation” and “conspiracy theories”. “There is undeniable evidence that there are serious risks associated with Covid-19 vaccine for at least some individuals,” he wrote. “At this point in time, the evidence of the Covid mRNA product doing significantly more harm than good is overwhelming, even for the highest-risk groups.” Professor Angus Dalgleish, head of oncology at St George’s Hospital in London, and Australian immunologist Robert Clancy, Emeritus Professor at the University of Newcastle, have backed Dr Malhotra’s claims in letters of support provided to the UK medical practitioners register. “Two of the world’s pre-eminent experts in oncology and immunology respectively feel there is strong mechanistic and clinical evidence through different pathways, including prolonged immunosuppression and DNA contamination, [that] the Covid mRNA vaccines cause cancer,” Dr Malhotra said. Prof Dalgleish, a prominent Covid sceptic , stated that he had “witnessed an outbreak of melanoma relapses in patients that had been stable on my immunotherapy treatment programs for over five to 18 years”. British cardiologist Dr Aseem Malhotra. Picture: GB News “The only thing they had in common is that they had all had booster vaccines which as predicted were causing T cell suppression,” he wrote. “I continue to see these relapses as well as rapid cancer progression after these totally unnecessary boosters. The tragedy is that all oncology doctors are seeing this but are afraid to speak out with a few exceptions.” Prof Clancy, who was denounced by the University of Newcastle in 2021 as “not an expert” on Covid after controversial comments supporting the use of hydroxychloroquine and ivermectin, said in his letter that the mRNA vaccines had “attracted a forest of red flags including unprecedented mortality and morbidity, unknown genetic confusion, and disappointing clinical value”. “Why is it that all doctors are not screaming for review of mRNA vaccines?” he wrote. Dr Malhotra is also supported in his GMC complaint by former Australian tennis champion Pat Cash, now a BBC commentator, and Jay Naidoo, a prominent South African trade unionist and anti-apartheid leader. “My advocacy to suspend the Covid-19 mRNA vaccine is not an isolated voice,” he wrote. “The longer the General Medical Council, the Secretary of State for Health, and the Chief Medical Officer delay on acting on this, the greater the harm to public health, the further decrease in trust in the medical profession, and the more strain on an already failing NHS.” A health worker prepares a dose of the Covid vaccine. Picture: Justin Tallis/AFP ‘No credible evidence’ Claims that Covid vaccines have contributed to a rise in excess deaths have repeatedly been rejected by the Australian government, including the Department of Health and Aged Care and the Australian Bureau of Statistics (ABS), as well as independent bodies like the Actuaries Institute, which maintain there is “no credible evidence” supporting such a link. The Health Department, which encourages Australians to “rely on reputable sources of information”, says Covid vaccines “have been thoroughly assessed by the Therapeutic Goods Administration (TGA) and found to be safe and effective”. “The TGA checks all Covid-19 vaccines for quality, safety and effectiveness before approving them for use in Australia,” it states on its website . “This is the same process that all vaccines go through in Australia. Medical experts at the TGA continuously check all vaccines to make sure they are safe. Vaccines are only approved for use in Australia after they have been assessed to show that the benefits of the vaccine outweigh any risks.” The Health Department notes that “millions of people around the world have now had Covid-19 vaccines, giving us real evidence and data that support using the vaccines” and “clinical trials and real-world data show that Covid-19 vaccines are highly effective at preventing severe illness”. Modelling by Monash University and RMIT earlier this year suggested the vaccine rollout saved nearly 18,000 lives in NSW between August 2021 and July 2022, during the end of the Delta wave and the arrival of Omicron. The World Health Organization (WHO) says that in 2021 alone, Covid vaccines “saved at least an estimated 14.4 million lives worldwide”. A recent paper in the journal Vaccines estimated the timely rollout of Covid jabs resulted in overall benefit to the Australian economy of $181 billion. frank.chung@news.com.au More Coverage UK professor rips Aussie Covid ‘madness’ Frank Chung Devastating warning for the next pandemic Jessica Wang Originally published as ‘Emergency no longer exists’: Doctors call for Covid vaccines to be pulled to reassess safety Read related topics: Donald Trump Illness Don't miss out on the headlines from Illness. Followed categories will be added to My News. Join the conversation Add your comment to this story To join the conversation, please log in. Don't have an account? Register Join the conversation, you are commenting as Logout More related stories Illness Shock find in pimple mum ‘squeezed too hard’ A young mother has issued a warning for Australians after discovering a “pimple” was in fact something much more sinister. Read more Illness ‘Awkward’: Doc reveals X-rated Xmas problem A doctor has revealed the Christmas gifts we should never buy if we want to avoid embarrassment or injury – including one naughty item. Read more
Nvidia's stock dips after China opens probe of the AI chip company for violating anti-monopoly lawsWhy Investors Were Slamming the Phone Down on T-Mobile US Stock Today
None
TORONTO — Canada's main stock index lost more than 100 points Tuesday ahead of an expected interest rate cut Wednesday, while U.S. markets were also down. The S&P/TSX composite index closed down 121.09 points at 25,504.33. In New York, the Dow Jones industrial average was down 154.10 points at 44,247.83. The S&P 500 index was down 17.94 points at 6,034.91, while the Nasdaq composite was down 49.45 points at 19,687.24. “Relative to the churn we have seen in the markets the last few days ... today being a little bit of a boring day would be fairly welcome for many investors,” said Stephen Duench, vice-president and portfolio manager for AGF Investments Inc. Wednesday is set to be more exciting, with an interest rate cut expected in Canada and important consumer inflation data coming in the U.S. “I do expect a little bit more fireworks tomorrow,” said Duench. The Bank of Canada is widely expected to announce an outsized cut Wednesday of half a percentage point, he said. “Anything other than that would be a surprise.” The U.S. Federal Reserve has its last decision of the year scheduled for next week, and market watchers are leaning toward a smaller quarter-percentage-point cut there, said Duench. It would be the third cut this year after the central bank hiked rates to a two-decade high to fight inflation. The inflation report will be the last significant data point before the central bank’s decision, Duench said. If the inflation report shows price growth is proving more stubborn than expected, that could change the Fed’s thinking on rates next week, he said. “Maybe that's part of the reason we've seen churn in the market the last few days in the U.S.” Beneath the surface, there was some movement in the tech sector, where Oracle sank 6.7 per cent after its latest earnings report missed expectations. Meanwhile, Google's stock price rose by more than five per cent. The company on Tuesday unveiled its new chip meant for quantum computing. Duench said after the advent of artificial technology led a rally earlier this year, quantum computing could be another frontier for investors to keep an eye on. The Canadian dollar traded for 70.59 cents US compared with 70.77 cents US on Monday. The January crude oil contract was up 12 cents at US$68.59 per barrel and the January natural gas contract was down two cents at US$3.16 per mmBTU. The February gold contract was up US$32.60 at US$2,718.40 an ounce and the March copper contract was down less than a penny at US$4.27 a pound. — With files from The Associated Press This report by The Canadian Press was first published Dec. 10, 2024. Companies in this story: (TSX:GSPTSE, TSX:CADUSD) Rosa Saba, The Canadian PressCHATTANOOGA, Tenn. (AP) — Rafael Pinzon had 22 points in Bryant's 97-85 win over Tennessee State on Tuesday night. Pinzon shot 6 of 15 from the field, including 4 for 5 from 3-point range, and went 6 for 6 from the line for the Bulldogs (4-3). Connor Withers scored 17 points while going 6 of 14 from the floor, including 4 for 9 from 3-point range, and 1 for 4 from the line. Keyshawn Mitchell finished 7 of 10 from the field to finish with 16 points, while adding 13 rebounds. Brandon Weston led the way for the Tigers (3-5) with 24 points and six steals. Antoine Lorick III added 16 points, seven rebounds and two steals for Tennessee State. Carlous Williams had 16 points and two steals. The Associated Press created this story using technology provided by Data Skrive and data from Sportradar .BURBANK, Calif. (AP) — BURBANK, Calif. (AP) — Loop Media Inc. (LPTV) on Tuesday reported a loss of $6.2 million in its fiscal fourth quarter. On a per-share basis, the Burbank, California-based company said it had a loss of 7 cents. The multichannel streaming platform posted revenue of $3.7 million in the period. For the year, the company reported a loss of $24.5 million, or 33 cents per share. Revenue was reported as $22.3 million. This story was generated by Automated Insights ( http://automatedinsights.com/ap ) using data from Zacks Investment Research. Access a Zacks stock report on LPTV at https://www.zacks.com/ap/LPTVBy Dalton Fowles, Country Manager at Mastercard Caribbean As Trinidad and Tobago embraces the digital age, the way we do transactions is also evolving. Digital payments, from contactless cards to mobile wallets, are becoming increasingly integrated into our daily lives, offering convenience and efficiency. However, this progress needs to come with a robust strategy on cybersecurity. A 2020 Cybersecurity Insights Report by Deloitte revealed that 43% of financial institutions in the Caribbean experienced a cyberattack in the prior year, highlighting the vulnerability of digital infrastructure in the region. Mastercard has been a pioneer in securing digital payments for over 50 years. Our commitment to cybersecurity is deeply ingrained in our operations and innovations, ensuring that every transaction is safe, secure, and seamless. We recognize that a secure digital environment is crucial for individuals, businesses, and governments to fully embrace digital payments and place their trust in technology. Understanding the Cyber Threat Landscape According to The World Bank's Global Findex Database 2021 , over 80% of adults in Trinidad and Tobago have an account at a financial institution, indicating a high level of financial inclusion, this also presents a tempting target for cybercriminals who are employing sophisticated tactics to exploit vulnerabilities and compromise sensitive financial data. This poses a significant challenge for governments tasked with protecting critical infrastructure and national security from cyber threats. Consumers are also vulnerable, facing threats like identity theft, financial fraud, and privacy breaches. Therefore, companies must prioritize safeguarding their data, systems, and reputations from cyberattacks. Cybersecurity Data and Solutions Mastercard leverages its vast network intelligence and advanced technologies to develop innovative cybersecurity solutions that protect consumers and businesses in the island. We understand that cybersecurity is not a one-size-fits-all approach, so we offer a multi-layered defense system that addresses various aspects of digital security. One crucial aspect is user risk assestment. Our RiskRecon solution, which identifies vulnerabilities in organizations' systems and recommends actions to strengthen their security posture. This proactive approach helps businesses stay ahead of evolving cyber threats and protect their valuable data. RiskRecon analyzes a wide range of factors, including network configurations, software vulnerabilities, and employee security practices, providing a comprehensive view of an organization's cyber risk profile. AI Solutions Artificial intelligence (AI) is playing an increasingly important role in enhancing cybersecurity and improving the digital payments experience. Mastercard is at the forefront of this evolution, our AI-powered solutions are designed to analyze vast amounts of data, identify patterns, and predict potential threats, enabling us to proactively prevent fraud and cyberattacks. For example, our AI algorithms can detect anomalies and suspicious activities in real time, flagging potentially fraudulent transactions for further investigation. This helps us protect consumers and businesses from financial losses and maintain the integrity of the digital payments ecosystem. We also use AI to personalize security measures, tailoring them to individual users based on their risk profiles and preferences. This ensures a more seamless and secure experience for everyone, without compromising convenience. A Secure Foundation for a Thriving Digital Economy As Trinidad and Tobago continues its digital transformation, ensuring the security of financial transactions is crucial to fostering trust and unlocking the full potential of our digital economy. By leveraging advanced technologies, collaborating with key stakeholders, and prioritizing a human-centric approach, we can create a digital environment where innovation and security go hand in hand. A secure digital economy is not just about preventing fraud and cyberattacks; it's about creating an environment where consumers and businesses feel confident and empowered to embrace the digital world. Mastercard is committed to playing a leading role in this journey, empowering confidence in digital payments and building a more secure digital future for all.
PHILADELPHIA (AP) — Former Temple basketball standout Hysier Miller sat for a long interview with the NCAA as it looked into concerns about unusual gambling activity, his lawyer said Friday amid reports a federal probe is now under way. “Hysier Miller fully cooperated with the NCAA’s investigation. He sat for a five-hour interview and answered every question the NCAA asked. He also produced every document the NCAA requested,” lawyer Jason Bologna said in a statement. “Hysier did these things because he wanted to play basketball this season, and he is devastated that he cannot.” Miller, a three-year starter from South Philadelphia, transferred to Virginia Tech this spring. However, the Hokies released him last month due to what the program called “circumstances prior to his enrollment at Virginia Tech.” Bologna declined to confirm that a federal investigation had been opened, as did spokespeople for both the FBI and the U.S. Attorney’s Office in Philadelphia. ESPN, citing unnamed sources, reported Thursday that authorities were investigating whether Miller bet on games he played in at Temple, and whether he adjusted his performance accordingly. “Hysier Miller has overcome more adversity in his 22 years than most people face in their lifetime. He will meet and overcome whatever obstacles lay ahead," Bologna said. Miller scored eight points — about half his season average of 15.9 — in a 100-72 loss to UAB on March 7 that was later flagged for unusual betting activity. Temple said it has been aware of those allegations since they became public in March, and has been cooperative. “We have been fully responsive and cooperative with the NCAA since the moment we learned of the investigation,” Temple President John Fry said in a letter Thursday to the school community. However, Fry said Temple had not received any requests for information from state or federal law enforcement agencies. He vowed to cooperate fully if they did. “Coaches, student-athletes and staff members receive mandatory training on NCAA rules and regulations, including prohibitions on involvement in sports wagering," Fry said in the letter. The same week the Temple-UAB game raised concerns, Loyola (Maryland) said it had removed a person from its basketball program after it became aware of a gambling violation. Temple played UAB again on March 17, losing 85-69 in the finals of the American Athletic Conference Tournament. League spokesman Tom Fenstermaker also declined comment on Friday. Get poll alerts and updates on the AP Top 25 throughout the season. Sign up here . AP college basketball: https://apnews.com/hub/ap-top-25-college-basketball-poll and https://apnews.com/hub/college-basketball Copyright 2024 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission. Get local news delivered to your inbox!